Compare Alcon AG (ALC) vs Vertiv Holdings Co (VRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Vertiv Holdings Co — how do they compare? Alcon AG trades at $72.61 (market cap $36.44B), while Vertiv Holdings Co trades at $292.74 (market cap $108.49B). The key difference: Vertiv Holdings Co is far larger — about 3× Alcon AG's market cap, and Alcon AG pays the higher dividend (0.48%). Which is the better fit depends on your goals.
| ALC | VRT | |
|---|---|---|
Market Cap | $36.44B | $108.49B |
Sector | Health | Technology |
52-Week High | $90.12 | $376.23 |
52-Week Low | $62.02 | $121.82 |
Enterprise Value | $40.28B | $108.72B |
Dividend Yield | 0.48% | 0.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $73.63, up 2.53% today, with a bullish technical signal from moving averages and strong recent earnings beats. Revenue growth is steady, reaching $10.40B in 2025, though net income margin dipped to 5.92%. Positive news includes raised 2026 profit guidance and new product launches driving investor optimism.
The outlook is positive with a consensus price target of $86.67 implying 17.7% upside, supported by analyst buy ratings. Risks include elevated P/E of 57.52 and potential tariff impacts, but operational cash flow strength and strategic collaborations provide a solid foundation for growth.
Vertiv (VRT) trades at $297.49, up 10.14% in the last 24 hours, reflecting strong momentum driven by AI infrastructure demand. The stock exhibits a bullish technical trend with key resistance near $293 and support at $270. Fundamentally, the company shows robust growth with revenue rising to $10.23B in 2025 and net income reaching $1.33B, supported by a high ROE of 43.94%. Recent earnings beats and a consensus analyst price target of $386.58 highlight positive sentiment, though elevated valuation ratios like a P/E of 63.76 warrant caution.
The outlook for VRT remains positive due to its strategic position in the AI data center market, with projected revenue growth to $11.5B in 2026. However, risks include high valuation multiples, ongoing legal investigations, and dependence on tech sector capital expenditure cycles. Investors should weigh the growth potential against these factors, with analyst consensus strongly favoring a buy rating.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →
